Bullish Sentiment
Share this article
Spread the word on social media
What the April Order Did, and What It Did Not Do
The Department of Justice's April 23, 2026 final order moved qualifying state-licensed medical marijuana operations to Schedule III of the Controlled Substances Act. Before that action, Section 280E of the Internal Revenue Code barred businesses trafficking in Schedule I or Schedule II substances from deducting ordinary and necessary business expenses. Only Cost of Goods Sold could reduce taxable income. State-licensed operators routinely paid far higher effective federal tax rates than comparable businesses because payroll, rent, utilities, insurance, marketing, and administrative costs were nondeductible.
The 2026 order removed that barrier for qualifying medical operators going forward. It did not resolve the treatment of prior tax years, and it did not guarantee refunds for taxes previously paid. The order encouraged the Department of the Treasury to consider whether retrospective relief should be available. That leaves the entire retroactive question to future Treasury and IRS guidance rather than the rescheduling order itself. Any discussion of prior-year refunds remains speculative until that framework arrives.
The ALJ Hearing and Why It Matters
The administrative law judge hearing that ran from June 29 through mid-July 2026 addressed the separate and larger question: whether rescheduling should extend beyond qualifying medical programs to adult-use cannabis. The April order applies only to marijuana distributed under qualifying state medical licensing programs and certain FDA-approved products. Recreational operations remain under Section 280E today.
The hearing record now sits with the ALJ, who must issue findings before any final agency action. The stakes are direct: an adult-use extension would collapse the medical-versus-recreational tax divide and would likely force Treasury to accelerate comprehensive 280E guidance. A narrow outcome preserves the current two-track system, in which the same multi-state operator can hold deductible medical operations and nondeductible adult-use operations inside one entity and one building.
Industry consensus places the probability of adult-use Schedule III movement through this process at twenty-five to forty percent, reflecting political and regulatory headwinds along with the ALJ's discretion on timing. Findings are not expected quickly, and appeals could extend the process well into 2027.
The Retroactive Relief Question
Under Section 6511 of the Internal Revenue Code, taxpayers generally have three years from the filing of a return, or two years from payment of tax, whichever is later, to file refund claims. Operators that paid taxes in full compliance with Section 280E may pursue amended returns or protective refund claims if Treasury ultimately authorizes retrospective relief. Filing protective claims now stops the statute clock on years that would otherwise close.
No final Treasury guidance has confirmed that qualifying medical operators may amend prior-year returns solely because of the rescheduling order. The IRS has instead issued No Consideration letters on 280E amended claims, routing disputes toward appeals rather than approving refunds. The realistic best case for a fully compliant operator is a multi-year recovery path, not immediate liquidity.
Company Postures Illustrate the Range
Individual operators adopted very different strategies during the 280E era, and those choices now shape their exposure and opportunity. Green Thumb Industries $GTBIF historically held a reputation as one of the industry's more conservative federal taxpayers. Beginning with tax year 2024, however, the company disclosed in SEC filings that it adopted an uncertain tax position, concluding that Section 280E did not apply to its business under its interpretation of applicable law. Even the conservative benchmark shifted before rescheduling arrived.
Trulieve Cannabis Corp. $TRLV moved earlier and more aggressively. The company filed amended federal returns seeking roughly one hundred forty-three million dollars in 280E refunds, reported receiving significant refunds, and simultaneously recognized hundreds of millions of dollars in uncertain tax position liabilities tied to its federal treatment. The rescheduling order alone does not validate those positions. Retrospective protection would require additional Treasury action or favorable judicial outcomes.
The lesson for readers is that the sector no longer sorts into a clean compliant-versus-aggressive split. Most large operators now carry some form of uncertain tax position, which makes Treasury's retroactive decision the single variable with the widest financial consequences across the industry.
The Probability Framework
Forward-looking relief for qualifying medical operations is the firmest ground. The probability that qualifying medical operators deduct ordinary business expenses for the full 2026 tax year is high, roughly seventy-five to eighty percent, supported by the explicit terms of the April order.
Retroactive relief for prior years is far less certain. Given the DOJ order's permissive rather than mandatory language, the IRS posture on amended claims, and the absence of any proposed Treasury framework, the probability of meaningful prior-year relief for compliant medical operators lands at roughly forty to fifty percent, and any recovery would likely arrive through a three to five year process of amended returns and appeals.
Adult-use rescheduling through the ALJ process carries a probability of twenty-five to forty percent, with timing extending into 2027 or beyond. Expense allocation guidance for bifurcated operators, demanded by seven House Democrats in a June 2026 letter covering rent, labor, utilities, and shared facility costs, is expected in the fourth quarter of 2026 at the earliest, with a sixty to seventy percent probability of clear medical-only guidance before year-end.
Statutes of limitation remain open at roughly ninety-five percent confidence for 2023 and later years, which is why protective refund claims are being filed across the sector now.
Key Takeaway
Investors should separate the confirmed change from the open questions. The confirmed change is prospective: qualifying medical operations should now deduct ordinary business expenses like any other Schedule III business, which structurally improves cash flow. The open questions are retroactive relief, adult-use rescheduling, and allocation methodology, and each sits with Treasury, the IRS, or the ALJ rather than with the operators themselves. Until definitive guidance is issued, any estimate of refund amounts, recovery probabilities, or company-specific benefits should be treated as an analytical scenario rather than an established fact. The ALJ findings and the first formal Treasury signal on prior years are the two catalysts to watch especially since the “Ides of March” are officially over.
Sources
https://mjbizdaily.com/news/marijuana-rescheduling-how-far-back-will-280e-cannabis-tax-relief-go/
https://www.gmlaw.com/news/schedule-iii-medical-marijuana/